+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Continuous Renal Replacement Therapy Market by Product, Modality, Age Group, Indication, End User - Forecast 2023-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5896406
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Continuous Renal Replacement Therapy Market size was estimated at USD 13.17 billion in 2022, USD 14.28 billion in 2023, and is expected to grow at a CAGR of 8.53% to reach USD 25.37 billion by 2030.

Continuous renal replacement therapy (CRRT) is a specialized medical treatment utilized for continuous dialysis to allow solute and fluid homeostasis. CRRT provides continuous renal support by mimicking the natural function of the kidneys in removing waste products, excess fluids, and electrolytes from the blood while maintaining optimal acid-base balance. The CRRT is witnessing significant growth due to several factors, including the increasing prevalence of AKI incidences globally and rising technological advancements in extracorporeal dialysis and lithotripsy. In addition, significant advantages of CRRT in intermittent blood purification boost the market expansion. However, the high cost associated with the renal replacement procedure and concerns over potential complications during therapies subsequently hampers the growth of CRRT. Moreover, ongoing innovation and research activities, including developing novel membrane materials and advanced therapy options with improved biocompatibility and widening uses of CCRT systems for pediatric patients, contribute to the future CRRT.

Regional Insights

In the Americas, countries such as the United States and Canada hold a significant share of the CRRT market, with the major factors driving the growth, including the increasing prevalence of renal diseases and technological advancements and research & development activities by major companies. Additionally, in Europe, the presence of leading manufacturers, increased need for advanced therapies, and supportive government policies, such as European CE marking for renal therapy products, contribute to the expansion of the CRRT market. On the other hand, the Middle East and Africa region has witnessed a growth in need for CRRT solutions due to rising awareness about renal diseases and continuously developing healthcare infrastructure adopting new treatment options supported by clinical studies. In Asia-Pacific, China, Japan, and India are major contributors to the CRRT market growth due to factors including a large patient pool with kidney disorders, a growing medical tourism industry, and expanding healthcare infrastructure, coupled with an increasing focus on research initiatives enabling rapid adoption of advanced technologies in this region. As a result, manufacturers remain agile by adapting regulatory compliance measures and participating in strategic collaborations with governments and entities to form footprints in the CRRT market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Continuous Renal Replacement Therapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Continuous Renal Replacement Therapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Continuous Renal Replacement Therapy Market, highlighting leading vendors and their innovative profiles. These include Anjue Medical Equipment Co., Ltd., Asahi Kasei Medical Co., Ltd., B. Braun SE, Baxter International Inc., Biomedica Medizinprodukte GmbH, Braun & Co. Limited, CytoSorbents Corporation, DIAMED Medizintechnik GmbH, Fresenius Medical Care AG & Co. KGaA, Infomed SA, Joline GmbH & Co. KG, Medites Pharma spol. s.r.o, Medtronic PLC, Miromatrix Medical Inc., Nextkidney B.V., Nikkiso Co., Ltd., Ningbo Tianyi Medical Devices Co., Ltd., Nipro Corporation, Nuwellis, Inc., Quanta Dialysis Technologies Limited, SB-KAWASUMI LABORATORIES, INC., Shionogi & Company, Limited, Sphingotec GmbH, SWS Hemodialysis Care Co. Ltd., Thermo Fisher Scientific Inc., and Toray Medical Co., Ltd. by Toray Industries, Inc.

Market Segmentation & Coverage

This research report categorizes the Continuous Renal Replacement Therapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • CRRT Systems
    • Dialysates & Replacement Fluids
    • Disposables
      • Bodyline sets & tubes
      • Hemofilters
  • Modality
    • Continuous Venovenous Hemodiafiltration
    • Continuous Venovenous Hemodialysis
    • Continuous Venovenous Hemofiltration
    • Slow Continuous Ultrafiltration
  • Age Group
    • Adults
    • Pediatrics
  • Indication
    • Non-renal
    • Renal
  • End User
    • Dialysis Clinics
    • Homecare
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Continuous Renal Replacement Therapy Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Continuous Renal Replacement Therapy Market?
  3. What are the technology trends and regulatory frameworks in the Continuous Renal Replacement Therapy Market?
  4. What is the market share of the leading vendors in the Continuous Renal Replacement Therapy Market?
  5. Which modes and strategic moves are suitable for entering the Continuous Renal Replacement Therapy Market?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Continuous Renal Replacement Therapy Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of acute kidney injury (AKI) and chronic kidney diseases (CKD)
5.1.1.2. Availability of improved CCRT systems for pediatric and neonatal patients
5.1.2. Restraints
5.1.2.1. High cost of continuous renal replacement therapy procedure
5.1.3. Opportunities
5.1.3.1. Ongoing research and development for enhanced safety and efficacy of CRRT
5.1.3.2. Favorable government approvals for CRRT machines and techniques
5.1.4. Challenges
5.1.4.1. Technical complications associated with continuous renal replacement therapy
5.2. Market Segmentation Analysis
5.2.1. Product: Growing prevalence toward acute kidney injury (AKI) boosting a need for CRRT devices for seamless treatment procedures
5.2.2. Modality: Utilization of continuous venovenous hemodiafiltration for liberal fluid management in renal therapies
5.2.3. Age Group: Differing CRRT requirements among pediatric population
5.2.4. Indication: Growing adoption of non-renal indications in extracorporeal renal therapies
5.2.5. End User: Increasing uses of CRRT devices in hospitals to cater a patients need
5.3. Market Trend Analysis
5.3.1. Established companies in the North America receiving favorable government approvals for CRRT and their potential expansion in the South American market
5.3.2. Growing number of renal patients in Asia leads to an increased need for continuous renal replacement therapies
5.3.3. Supportive government policies and financial initiatives from established vendors for the kidney health contributed to CRRT advancement across EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Continuous Renal Replacement Therapy Market, by Product
6.1. Introduction
6.2. CRRT Systems
6.3. Dialysates & Replacement Fluids
6.4. Disposables
6.5.1. Bodyline sets & tubes
6.5.2. Hemofilters
7. Continuous Renal Replacement Therapy Market, by Modality
7.1. Introduction
7.2. Continuous Venovenous Hemodiafiltration
7.3. Continuous Venovenous Hemodialysis
7.4. Continuous Venovenous Hemofiltration
7.5. Slow Continuous Ultrafiltration
8. Continuous Renal Replacement Therapy Market, by Age Group
8.1. Introduction
8.2. Adults
8.3. Pediatrics
9. Continuous Renal Replacement Therapy Market, by Indication
9.1. Introduction
9.2. Non-renal
9.3. Renal
10. Continuous Renal Replacement Therapy Market, by End User
10.1. Introduction
10.2. Dialysis Clinics
10.3. Homecare
10.4. Hospitals
11. Americas Continuous Renal Replacement Therapy Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Continuous Renal Replacement Therapy Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Continuous Renal Replacement Therapy Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Agreement, Collaboration, & Partnership
14.3.1.1. Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical
14.3.1.2. Nuwellis, DaVita partner on ultrafiltration therapy pilot program
14.3.1.3. Baxter, Miromatrix Partner on Liver Failure Research
14.3.1.4. SeaStar Medical, Nuwellis Partner on Kidney Injury Treatment
14.3.1.5. Spectral Medical Announces Strategic Joint Venture with Infomed to Accelerate Commercialization of DIMI and SAMI Dialysis Devices.
14.3.2. New Product Launch & Enhancement
14.3.2.1. PBMC Launches New Renal Therapy Option for Dialysis Patients
14.3.3. Award, Recognition, & Expansion
14.3.3.1. B. Braun Receives FDA Clearance for AQUAbase nX Reverse Osmosis System
14.3.3.2. Quanta Receives FDA 510(k) Clearance for Expanded Indication of Continuous Renal Replacement Therapies
14.3.3.3. Baxter Announces U.S. FDA Clearance of ST Set Used to Help Treat Acute Kidney Injury Patients in the Hospital
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Anjue Medical Equipment Co., Ltd.
15.1.2. Asahi Kasei Medical Co., Ltd.
15.1.3. B. Braun SE
15.1.4. Baxter International Inc.
15.1.5. Biomedica Medizinprodukte GmbH
15.1.6. Braun & Co. Limited
15.1.7. CytoSorbents Corporation
15.1.8. DIAMED Medizintechnik GmbH
15.1.9. Fresenius Medical Care AG & Co. KGaA
15.1.10. Infomed SA
15.1.11. Joline GmbH & Co. KG
15.1.12. Medites Pharma spol. s.r.o
15.1.13. Medtronic PLC
15.1.14. Miromatrix Medical Inc.
15.1.15. Nextkidney B.V.
15.1.16. Nikkiso Co., Ltd.
15.1.17. Ningbo Tianyi Medical Devices Co., Ltd.
15.1.18. Nipro Corporation
15.1.19. Nuwellis, Inc.
15.1.20. Quanta Dialysis Technologies Limited
15.1.21. SB-KAWASUMI LABORATORIES, INC.
15.1.22. Shionogi & Company, Limited
15.1.23. Sphingotec GmbH
15.1.24. SWS Hemodialysis Care Co. Ltd.
15.1.25. Thermo Fisher Scientific Inc.
15.1.26. Toray Medical Co., Ltd. by Toray Industries, Inc.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET RESEARCH PROCESS
FIGURE 2. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2022 VS 2030
FIGURE 3. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET DYNAMICS
FIGURE 7. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2022 VS 2030 (%)
FIGURE 10. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2022 VS 2030 (%)
FIGURE 12. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AGE GROUP, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 14. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 16. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 20. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 26. CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2022

Companies Mentioned

  • Anjue Medical Equipment Co., Ltd.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun SE
  • Baxter International Inc.
  • Biomedica Medizinprodukte GmbH
  • Braun & Co. Limited
  • CytoSorbents Corporation
  • DIAMED Medizintechnik GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Infomed SA
  • Joline GmbH & Co. KG
  • Medites Pharma spol. s.r.o
  • Medtronic PLC
  • Miromatrix Medical Inc.
  • Nextkidney B.V.
  • Nikkiso Co., Ltd.
  • Ningbo Tianyi Medical Devices Co., Ltd.
  • Nipro Corporation
  • Nuwellis, Inc.
  • Quanta Dialysis Technologies Limited
  • SB-KAWASUMI LABORATORIES, INC.
  • Shionogi & Company, Limited
  • Sphingotec GmbH
  • SWS Hemodialysis Care Co. Ltd.
  • Thermo Fisher Scientific Inc.
  • Toray Medical Co., Ltd. by Toray Industries, Inc.

Methodology

Loading
LOADING...

Table Information